Quality assessment of HER2 testing by monitoring of positivity rates

Interlaboratory variation in human epidermal growth factor receptor 2 (HER2) testing provides a challenge for targeted therapy in breast and gastric cancer. Assessment of positivity rates among laboratories could help monitor their performance and define reference values for positivity rates to be e...

Descripción completa

Detalles Bibliográficos
Autores principales: Choritz, Harald, Büsche, Guntram, Kreipe, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162627/
https://www.ncbi.nlm.nih.gov/pubmed/21809092
http://dx.doi.org/10.1007/s00428-011-1132-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162627/
https://www.ncbi.nlm.nih.gov/pubmed/21809092
http://dx.doi.org/10.1007/s00428-011-1132-8

Ejemplares similares